HPP

September 27, 2022

Diagnostic biomarker for bone disorder

A urine chemical performs better as a diagnostic biomarker for the soft bone disease hypophosphatasia than other laboratory measures, Vanderbilt researchers have demonstrated.

By Leigh MacMillan
August 17, 2017

Dahir receives grant to support study of rare metabolic disorder

Kathryn Dahir, M.D., associate professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, recently received the Maher Family Grant from Soft Bones Inc., an organization dedicated to providing information, education and support to those affected by hypophosphatasia (HPP).

By Christina Echegaray
July 21, 2016

Young bone patient’s progress serves as inspiration to others

Janelly Martinez-Amador grabbed headlines and hearts around the world three years ago when news spread of her remarkable fight for survival against a rare metabolic disease at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

By Christina Echegaray